Close Menu

multiple myeloma

The firm also said it had a net loss of $7.9 million, or $3.50 per share, in 2014, compared to a net loss of $2.4 million, or $12.23 per share, in 2013.

The gift will go toward the creation of theBartBarlogieCenterfor Molecular Diagnostics and the Celgene Distinguished Endowed Chair for Molecular Therapeutics.

The company plans to offer about 3.2 million shares of its common stock at $2.80 per share. 

The FDA conditionally approved the microarray-based gene expression test for use as entry criteria for a clinical trial for an investigational new drug for multiple myeloma. 

GNS Healthcare and the Multiple Myeloma Research Foundation to use GNS' informatics solutions to explore genomic and clinical data from the CoMMpass study.

Cancer Genetics CEO Panna Sharma told GenomeWeb this week that the company plans to focus on very targeted panels of actionable mutations.

Using a combination of proteomic approaches, researchers from Boston's Brigham and Women's Hospital, the Broad Institute, and the Dana-Farber Cancer Institute have identified the mechanism of action of the multiple myeloma drug lenalidomide.

NEW YORK (GenomeWeb News) – Empire Genomics today said that its clinical laboratory facility has received CLIA certification and has been approved by the New York State Department of Health.

NEW YORK (GenomeWeb News) – Signal Genetics today said that Arkansas Blue Cross Blue Shield will cover the company's molecular assay for multiple myeloma.

The Multiple Myeloma Research Foundation is hoping that an open-access research portal containing detailed longitudinal clinical and genomic data from multiple myeloma patients will spur collaborative research that advances much needed molecularly-targeted treatments.

Pages

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.